OBDRŽÁLKOVÁ, Marie, Libor USTOHAL, Natasa HLAVACOVA, Michaela MAYEROVÁ, Eva ČEŠKOVÁ, Tomáš KAŠPÁREK and Daniela JEZOVA. Selected neuroendocrine factors as potential molecular biomarkers of early non-affective psychosis course in relation to treatment outcome: A pilot study. Heliyon. Oxford: Elsevier, 2023, vol. 9, No 10, p. 1-10. ISSN 2405-8440. Available from: https://dx.doi.org/10.1016/j.heliyon.2023.e21173.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Selected neuroendocrine factors as potential molecular biomarkers of early non-affective psychosis course in relation to treatment outcome: A pilot study
Authors OBDRŽÁLKOVÁ, Marie (203 Czech Republic, belonging to the institution), Libor USTOHAL (203 Czech Republic, belonging to the institution), Natasa HLAVACOVA, Michaela MAYEROVÁ (203 Czech Republic, belonging to the institution), Eva ČEŠKOVÁ (203 Czech Republic, belonging to the institution), Tomáš KAŠPÁREK (203 Czech Republic, belonging to the institution) and Daniela JEZOVA.
Edition Heliyon, Oxford, Elsevier, 2023, 2405-8440.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30215 Psychiatry
Country of publisher United Kingdom of Great Britain and Northern Ireland
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 4.000 in 2022
RIV identification code RIV/00216224:14110/23:00134686
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1016/j.heliyon.2023.e21173
UT WoS 001114112800001
Keywords in English Aldosterone; Cortisol; Non-affective psychosis
Tags 14110222, podil, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 3/1/2024 09:09.
Abstract
The aim of this pilot study was to find whether the dysregulation of neuroendocrine biomarker signaling pathways in the first episode of non-affective psychosis is a predictive factor of treat-ment outcome. Patients with the first episode of non-affective psychosis (N = 29) were examined at admission, at discharge, and at follow-up (N = 23). The biomarkers included serum aldoste-rone, cortisol, free thyroxine, thyroid stimulating hormone, and prolactin. We revealed lower baseline aldosterone and higher baseline cortisol concentrations in patients with very good outcome compared to those with good outcome after one year. We failed to reveal any significant association between treatment outcome and neurohumoral biomarkers in the whole sample at 1-year follow-up. However, baseline aldosterone concentrations negatively correlated with total PANSS scores at the discharge. Lower baseline aldosterone and higher baseline cortisol concentrations have the potential to predict a more favorable outcome for patients with the first episode of psychosis.
Links
NU23-08-00257, research and development projectName: Optimalizovaný longitudinální vlasový kortizol jako nástroj v diagnostice a monitorování psychiatrických poruch
Investor: Ministry of Health of the CR, Optimized longitudinal hair cortisol as a tool in diagnosis and monitoring of psychiatric disorders, Subprogram 1 - standard
PrintDisplayed: 16/7/2024 08:04